Transdermal delivery of treatment for Alzheimer's disease: development, clinical performance and future prospects.

Drugs & Aging
Agnes L F ChanShun Jin Lin

Abstract

There is increasing interest in the potential of transdermal drug delivery systems for the treatment of neurological disorders, especially in the elderly. In this population, the higher incidence of chronic diseases, such as diabetes mellitus, cardiovascular disease, neurological disease and chronic pain, has dramatically increased the need for long-term medications. Additionally, elderly patients often have a combination of several chronic diseases, meaning drug delivery, drug-drug interactions, absorption/blood concentrations, toxicity and compliance are of concern for patients as well as for their caregivers and physicians. Recent efforts have focused on developing pharmaceutical preparations that overcome these issues. For example, rate-controlled drug delivery systems have been under active development. Transdermal drug delivery systems have been developed to deliver phenserine, rivastigmine, nicotine and estradiol for the management of cognitive and behavioural dysfunctions in patients with Alzheimer's disease because this form of administration has several advantages, including maintenance of sustained therapeutic plasma concentrations of drugs, easy application and reduced systemic adverse effects. Thus, transdermal dru...Continue Reading

References

Jul 1, 1978·Neuropathology and Applied Neurobiology·E K PerryB E Tomlinson
Jun 1, 1995·Pharmacology, Biochemistry, and Behavior·A L WilsonJ R McCarten
Oct 28, 1998·Methods and Findings in Experimental and Clinical Pharmacology·H BenechJ M Grognet
May 29, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·T JaskariJ Hirvonen
Jul 6, 2000·Journal of Neuroscience Research·A K RainaM A Smith
Feb 13, 2001·Experimental Gerontology·E J RemarqueR G Westendorp
Feb 24, 2001·Annals of the New York Academy of Sciences·P S Green, J W Simpkins
Mar 23, 2001·Acta Neurologica Scandinavica. Supplementum·N H GreigT T Soncrant
May 22, 2002·Investigative Radiology·Laurent LemairePatrick J Cozzone
Jun 19, 2002·Pharmaceutical Research·Tarja KankkunenJouni Hirvonen
Aug 7, 2002·Clinical Pharmacokinetics·Michael W JannGary W Small
Sep 6, 2002·Journal of Molecular Neuroscience : MN·Abraham FisherZipora Pittel
Sep 6, 2002·Journal of Molecular Neuroscience : MN·William S Messer
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·Barbara J. BlanchardVernon M. Ingram
Nov 28, 2002·Clinical Pharmacokinetics·Yie W Chien, Senshang Lin
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·E D Levin, A H Rezvani
Jun 10, 2003·Alzheimer Disease and Associated Disorders·Sultan DarveshEarl Martin
Aug 20, 2003·Archives of Neurology·Liesi E HebertDenis A Evans
Nov 18, 2003·International Journal of Geriatric Psychiatry·Sudip Sikdar
Mar 25, 2004·The American Journal of Pathology·Christoph SchmitzThomas A Bayer
Jun 24, 2004·Neurobiology of Aging·Beatrice ArosioMario Clerici
Nov 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pascale N LacorWilliam L Klein
Jan 11, 2005·Neurobiology of Aging·Ira T Lott, Elizabeth Head
Jan 29, 2005·Dementia and Geriatric Cognitive Disorders·E RichartzK Schott
Feb 15, 2005·Biochemical and Biophysical Research Communications·Kyung Hyun LeeJaehoon Yu
Jun 3, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cathy AndorferPeter Davies
Jun 9, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Yiping WangBozena Michniak
Jul 30, 2005·International Psychogeriatrics·Kathryn A HallDaniel W O'Connor
Oct 26, 2005·Annals of Neurology·Khalid IqbalInge Grundke-Iqbal
Oct 27, 2005·Current Alzheimer Research·Nigel H GreigRobert G Burford
Jan 5, 2006·Dementia and Geriatric Cognitive Disorders·Bonnie Davis, Kay Sadik
Jan 13, 2006·Dementia and Geriatric Cognitive Disorders·A WimoB Winblad
Apr 29, 2006·Age and Ageing·Lary C Walker, Rebecca F Rosen

❮ Previous
Next ❯

Citations

Jun 6, 2009·Experimental Dermatology·John W MartinShaker A Mousa
Mar 12, 2011·Expert Opinion on Drug Delivery·Antonio Di StefanoPiera Sozio
Aug 28, 2015·Basic & Clinical Pharmacology & Toxicology·Soo-Han LeeChun-Sik Bae

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.